Thoratec-HeartWare LVAD Deal Is Dead Following FTC Challenge
This article was originally published in The Gray Sheet
Executive Summary
Thoratec abandoned its planned $282 million acquisition of ventricular-assist-device-maker HeartWare July 31 after the deal was challenged by the Federal Trade Commission